"when it should be Brazil, Brazil, Brazil..." N
Post# of 154721
(Total Views: 453)
Posted On: 05/25/2021 9:07:11 AM
Re: Evil Rabbit #91589
"when it should be Brazil, Brazil, Brazil..."
NP was laser focused on CD12 for months, put everything else on hold, yet, we ended up with so many missteps that promises were not delivered.
For NIH, LL has a 81% efficacy, yet no approval, meanwhile, Maraviroc got approved with 45% efficacy and severe side effects, and Ibalizumab got approved with some side effects and 43% of efficacy.
No matter how laser focused NP is, no matter how solid science is behind LL, no matter how successful trial results CYDY may have, NP could not get an approval. FDA doesn't want to work with NP.
Some say ' Science will prevail', yes, some day it will, but how long? HIV trail was completed three years ago, we are still in the process of submitting BLA. Who knows what else FDA will come back that may take another three years, and then another three years back and forth?
I agree NP has passion and love for LL, and am grateful that he took us to where we are now, but he has done his part for LL, now it's time for LL to have someone who knows how to work with the FDA to carry it through the finish line.
GLTA.
NP was laser focused on CD12 for months, put everything else on hold, yet, we ended up with so many missteps that promises were not delivered.
For NIH, LL has a 81% efficacy, yet no approval, meanwhile, Maraviroc got approved with 45% efficacy and severe side effects, and Ibalizumab got approved with some side effects and 43% of efficacy.
No matter how laser focused NP is, no matter how solid science is behind LL, no matter how successful trial results CYDY may have, NP could not get an approval. FDA doesn't want to work with NP.
Some say ' Science will prevail', yes, some day it will, but how long? HIV trail was completed three years ago, we are still in the process of submitting BLA. Who knows what else FDA will come back that may take another three years, and then another three years back and forth?
I agree NP has passion and love for LL, and am grateful that he took us to where we are now, but he has done his part for LL, now it's time for LL to have someone who knows how to work with the FDA to carry it through the finish line.
GLTA.
(3)
(1)